Successful treatment of congestive heart failure with concomitant administration of tolvaptan to enhance the effects of furosemide

Tolvaptan (TLV), which is an antagonist to the vasopressin V2 receptor, was approved by Japanese authorities for the treatment of “volume overload in heart failure when adequate response is not obtained with other diuretics (e.g. loop diuretics)”. An 82-year-old female Japanese patient was admitted...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cardiol Cases
Autors principals: Nishizaki, Yuji, Yamagami, Shinichiro, Sesoko, Masahiro, Yamashita, Haruyo, Daida, Hiroyuki
Format: Artigo
Idioma:Inglês
Publicat: Japanese College of Cardiology 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277594/
https://ncbi.nlm.nih.gov/pubmed/30546768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2013.07.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars